Investor Relations
If you are a current shareholder and your contact information has changed or you are not getting our updates, please reach out to us at investorrelations@glytec.com
BREAKING NEWS! CMS has announced new proposed mandated reporting on Diabetes Harm Measures, including severe Hypo and Hyperglycemic events. Learn More
If you are a current shareholder and your contact information has changed or you are not getting our updates, please reach out to us at investorrelations@glytec.com